As of September 2024, Oncopeptides AB has a market cap of $19.06M. This makes Oncopeptides AB the world's 30342th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $63.53M | -6.01% |
2023 | $67.59M | -36.95% |
2022 | $107.20M | 44.64% |
2021 | $74.12M | -95.05% |
2020 | $1.50B | 33.73% |
2019 | $1.12B | -3.42% |
2018 | $1.16B | 64.25% |
2017 | $705.87M | - |